Learn More
Apexbio Technology LLC Sulfatinib 1308672-74-3 1mg

Supplier: Apexbio Technology LLC A47421
Sulfatinib (CAS 1308672-74-3) is a small-molecule tyrosine kinase inhibitor that selectively targets vascular endothelial growth factor receptors (VEGFR) 1-3 fibroblast growth factor receptor 1 (FGFR1) and colony-stimulating factor-1 receptor (CSF1R) By inhibiting these signaling pathways sulfatinib disrupts tumor angiogenesis and modulates the tumor microenvironment The compound is currently being evaluated in clinical studies for the treatment of advanced neuroendocrine tumors including a phase III trial in patients with extrapancreatic neuroendocrine tumors supporting its application in cancer research focused on anti-angiogenic therapy
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.